Show simple item record

Safety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortium

dc.contributor.authorZwaan, CMen_US
dc.contributor.authorDworzak, Men_US
dc.contributor.authorKlingebiel, Ten_US
dc.contributor.authorRossig, Cen_US
dc.contributor.authorLeverger, Gen_US
dc.contributor.authorStary, Jen_US
dc.contributor.authorDe Bont, ESen_US
dc.contributor.authorRamnarain, Sen_US
dc.contributor.authorBertrand, Yen_US
dc.contributor.authorGhazaly, EAen_US
dc.contributor.authorReinhardt, Den_US
dc.date.accessioned2015-02-23T12:53:38Z
dc.date.accessioned2015-06-16T11:50:27Z
dc.date.issued2013-11-15en_US
dc.identifier.issn0006-4971en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/7699
dc.descriptionThis study was financially supported by Sanofi and by the KiKa-foundation grant nr. 26.
dc.relation.replaceshttp://qmro.qmul.ac.uk/jspui/handle/123456789/6673
dc.relation.replaces123456789/6673
dc.titleSafety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortiumen_US
dc.typeConference Proceeding
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000331385005405&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue21en_US
pubs.notesNo embargoen_US
pubs.publication-statusPublisheden_US
pubs.volume122en_US


Files in this item

Thumbnail
Name:
ENGEL-GOUGHSafetyPharmacokinet ...
Size:
32.5Kb
Format:
application/
Description:
Accepted version
View/Open

This item appears in the following Collection(s)

Show simple item record